ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.1, 2012-01, pp. : 182-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 311-321

Spandidos Publications

Access to resources Recommend Favorite

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 557-562

Spandidos Publications

Access to resources Recommend Favorite

Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self-renewal of lung cancer stem cells

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 363-370

Spandidos Publications

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite

Effect of Huaier on the proliferation and apoptosis of human gastric cancer cells through modulation of the PI3K/AKT signaling pathway

Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. : 1212-1218

Spandidos Publications

Access to resources Recommend Favorite